Hemlibra in Mild Hemophilia A

Clinical trial NCT04567511 · RECRUITING

Trial details

NCT number: NCT04567511
Sponsor: Indiana Hemophilia &Thrombosis Center, Inc.
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Factor VIII Deficiency, Congenital

Start date: 2022-07-25
Primary completion: 2025-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.